These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37937579)

  • 21. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
    Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
    Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of regulatory T cells by natural products in cancer.
    Bahrami A; Fereidouni M; Pirro M; Bianconi V; Sahebkar A
    Cancer Lett; 2019 Sep; 459():72-85. PubMed ID: 31176742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distepharinamide, a novel dimeric proaporphine alkaloid from Diploclisia glaucescens, inhibits the differentiation and proliferative expansion of CD4
    Chen FY; Geng CA; Chou CK; Zheng JB; Yang Y; Wang YF; Li TZ; Li P; Chen JJ; Chen X
    Phytomedicine; 2022 Dec; 107():154482. PubMed ID: 36202057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Regulatory T Cells in Cancer Treatment Resistance.
    Dąbrowska A; Grubba M; Balihodzic A; Szot O; Sobocki BK; Perdyan A
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
    Overacre-Delgoffe AE; Vignali DAA
    Cancer Immunol Res; 2018 Aug; 6(8):882-887. PubMed ID: 30068755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting FOXP3 complex ensemble in drug discovery.
    Huang J; Wang S; Jia Y; Zhang Y; Dai X; Li B
    Adv Protein Chem Struct Biol; 2020; 121():143-168. PubMed ID: 32312420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cells and asthma.
    Robinson DS
    Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
    Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
    J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells.
    Beauford SS; Kumari A; Garnett-Benson C
    BMC Immunol; 2020 Apr; 21(1):18. PubMed ID: 32299365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral Circulating CD45RA
    Pai SI; Marincola FM
    Trends Cancer; 2020 Jan; 6(1):3-6. PubMed ID: 31952778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harnessing proteases for T regulatory cell immunotherapy.
    Amarnath S; Brown ML
    Eur J Immunol; 2020 Jun; 50(6):770-778. PubMed ID: 32383480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.
    Chung DJ; Rossi M; Romano E; Ghith J; Yuan J; Munn DH; Young JW
    Blood; 2009 Jul; 114(3):555-63. PubMed ID: 19465693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased tumor-infiltrating CD45RA
    Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
    Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models.
    Stirm K; Leary P; Wüst D; Stark D; Joller N; Karakus U; Boyman O; Tzankov A; Müller A
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
    La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
    Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
    Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
    J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.
    Klauber TCB; Laursen JM; Zucker D; Brix S; Jensen SS; Andresen TL
    Acta Biomater; 2017 Apr; 53():367-377. PubMed ID: 28153581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2.
    Tsyklauri O; Chadimova T; Niederlova V; Kovarova J; Michalik J; Malatova I; Janusova S; Ivashchenko O; Rossez H; Drobek A; Vecerova H; Galati V; Kovar M; Stepanek O
    Elife; 2023 Jan; 12():. PubMed ID: 36705564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting regulatory T cells in tumors.
    Liu C; Workman CJ; Vignali DA
    FEBS J; 2016 Jul; 283(14):2731-48. PubMed ID: 26787424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T cells in tumor immunity.
    Nishikawa H; Sakaguchi S
    Int J Cancer; 2010 Aug; 127(4):759-67. PubMed ID: 20518016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.